November 03, 2025

Get In Touch

Our Twitter Handle Compromised, Says ICMR

ICMR Twitter Account Compromised

ICMR Twitter Account Compromised

New Delhi: The Indian Council of Medical Research (ICMR) said on Wednesday evening that its Twitter account has been "compromised" and it was taking necessary steps to rectify the issue.

According to sources, it was observed that certain tweets criticizing the government were "liked" from the ICMR's official Twitter handle. The matter was brought to the notice of ICMR officials by some Twitter users, they said.

Read Also

  • COVID-19 can infect pregnant women's placenta, finds ICMR Study

"ICMR has observed that the Twitter account of the organization has been compromised. We are taking the necessary steps to rectify the same. We apologize for any inconvenience caused due to this situation," the apex health research body said in a tweet.

The ICMR has removed its likes on the tweets in question.

Read Also

  • NEET 2020: #ResignNishankPokhriyal trends on Twitter

Disclaimer: This website is designed for healthcare professionals and serves solely for informational purposes.
The content provided should not be interpreted as medical advice, diagnosis, treatment recommendations, prescriptions, or endorsements of specific medical practices. It is not a replacement for professional medical consultation or the expertise of a licensed healthcare provider.
Given the ever-evolving nature of medical science, we strive to keep our information accurate and up to date. However, we do not guarantee the completeness or accuracy of the content.
If you come across any inconsistencies, please reach out to us at admin@doctornewsdaily.com.
We do not support or endorse medical opinions, treatments, or recommendations that contradict the advice of qualified healthcare professionals.
By using this website, you agree to our Terms of Use, Privacy Policy, and Advertisement Policy.
For further details, please review our Full Disclaimer.

0 Comments

Post a comment

Please login to post a comment.

No comments yet. Be the first to comment!